Patent Assignment
Reel/Frame 052497/0213
Change of Name
Recorded: 2020-04-27
Pages: 3
Assignor
PRILENIA THERAPEUTICS DEVELOPMENT LTD.
Executed: 2019-05-02
Assignee
PRILENIA NEUROTHERAPEUTICS LTD.
HAMENOFIM 10, HERZLIYA, 4672561, ISRAEL
Covered Property
(1)
Use of Pridopidine for the Treatment of Anxiety and Depression
Application:
16/332,366 →
Publication:
US 2020/0375966
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.